[Genetic diagnosis of hepatitis C virus infection]
- PMID: 10337182
[Genetic diagnosis of hepatitis C virus infection]
Abstract
Hepatitis C virus, a small enveloped RNA member of Flaviviridae, is the major causative agent of non-A, non-B hepatitis. The discovery and genetic characterization of HCV is described. Modern genetic procedures and methods involved in the studies of HCV biology, genetic heterogenity and diagnostics of HCV infections are presented. Interferon-alfa treatment is the only licensed therapy for chronic hepatitis C until now, but an efficacy of such treatment is highly variable. Viral factors predicting the long-term outcome of interferon alfa therapy, such as genotype, baseline viral load, quasispecies or ISDR mutations, and current concepts of their predictive values are discussed. Our own results are presented and compared with those present in the latest publications.
Similar articles
-
Hepatitis C: changing genotype distribution with important implications for patient management.Neth J Med. 2006 Apr;64(4):96-9. Neth J Med. 2006. PMID: 16609154 Review.
-
Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.Med Sci Monit. 2000 Sep-Oct;6(5):964-70. Med Sci Monit. 2000. PMID: 11208439
-
Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.Transl Res. 2006 Sep;148(3):120-7. doi: 10.1016/j.trsl.2006.04.006. Transl Res. 2006. PMID: 16938649
-
Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.J Med Virol. 2006 Mar;78(3):365-71. doi: 10.1002/jmv.20548. J Med Virol. 2006. PMID: 16419107
-
Treatment predictors of a sustained virologic response in hepatitis B and C.J Hepatol. 2008 Oct;49(4):634-51. doi: 10.1016/j.jhep.2008.07.013. Epub 2008 Jul 31. J Hepatol. 2008. PMID: 18715665 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical